ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 091,97
-0,15%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Bausch plus Lomb Corporation (BLCO)

  7. Bausch plus Lomb Corporation (BLCO) Actualités

BLCO

Bausch plus Lomb (BLCO)

Bausch plus Lomb Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:BLCO
DateHeureSourceTitreSymboleSociété
10/06/202413h00Business WireBausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United StatesNYSE:BLCOBausch plus Lomb Corporation
03/06/202413h00Business WireBausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United StatesNYSE:BLCOBausch plus Lomb Corporation
29/05/202422h44Edgar (US Regulatory)Form 8-K - Current reportNYSE:BLCOBausch plus Lomb Corporation
29/05/202422h30Business WireBausch + Lomb Announces 2024 Annual Meeting of Shareholder ResultsNYSE:BLCOBausch plus Lomb Corporation
28/05/202415h00Business WireBausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®NYSE:BLCOBausch plus Lomb Corporation
28/05/202412h59Business WireBausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular LensNYSE:BLCOBausch plus Lomb Corporation
07/05/202415h09IH Market NewsFutures Pointing To Roughly Flat Open On Wall StreetNYSE:BLCOBausch plus Lomb Corporation
06/05/202422h34IH Market NewsU.S. Stocks See Further Upside Amid Renewed Interest Rate OptimismNYSE:BLCOBausch plus Lomb Corporation
01/05/202412h58Business WireBausch + Lomb Announces First-Quarter 2024 ResultsNYSE:BLCOBausch plus Lomb Corporation
29/04/202413h00Business WireBausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual MeetingNYSE:BLCOBausch plus Lomb Corporation
25/04/202414h30Business WireBausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry EyesNYSE:BLCOBausch plus Lomb Corporation
18/04/202413h00Business WireBausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling ProgramsNYSE:BLCOBausch plus Lomb Corporation
15/04/202418h00Business WireBausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1NYSE:BLCOBausch plus Lomb Corporation
27/03/202412h00Business WireBausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual MeetingNYSE:BLCOBausch plus Lomb Corporation
04/03/202423h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
28/02/202414h00Business WireBausch + Lomb Announces Appointment of Karen L. Ling to Board of DirectorsNYSE:BLCOBausch plus Lomb Corporation
21/02/202413h00GlobeNewswire Inc.Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEONYSE:BLCOBausch plus Lomb Corporation
21/02/202412h58Business WireBausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 GuidanceNYSE:BLCOBausch plus Lomb Corporation
05/02/202418h00Business WireBausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 Financial Results on February 21NYSE:BLCOBausch plus Lomb Corporation
08/01/202412h59Business WireBausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction SurgeryNYSE:BLCOBausch plus Lomb Corporation
03/01/202415h00Business WireBausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:BLCOBausch plus Lomb Corporation
15/11/202312h59Business WireBausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling ProgramsNYSE:BLCOBausch plus Lomb Corporation
13/11/202322h47Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:BLCOBausch plus Lomb Corporation
01/11/202322h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BLCOBausch plus Lomb Corporation
01/11/202311h58Business WireBausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 GuidanceNYSE:BLCOBausch plus Lomb Corporation
26/10/202312h59Business WireBausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Ophthalmology Annual MeetingNYSE:BLCOBausch plus Lomb Corporation
16/10/202318h00Business WireBausch + Lomb Will Release Third-Quarter 2023 Financial Results on November 1NYSE:BLCOBausch plus Lomb Corporation
04/10/202312h59Business WireBausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual MeetingNYSE:BLCOBausch plus Lomb Corporation
29/09/202316h00Business WireBausch + Lomb Completes Acquisition of XIIDRA®NYSE:BLCOBausch plus Lomb Corporation
26/09/202312h59Business WireBausch + Lomb Launches LUMIFY EYE ILLUMINATIONS™ in the United StatesNYSE:BLCOBausch plus Lomb Corporation
 Showing the most relevant articles for your search:NYSE:BLCO

Dernières Valeurs Consultées

NYSE
MCD
McDonalds
EU
HO
Thales
FTSE
UKX
FTSE 100
NASDAQ
AMZN
Amazon.com
NYSE
DIS
Walt Disney
NYSE
NKE
Nike
NYSE
KO
Coca Cola
EU
SGO
Cie de SaintGobain
EU
RI
Pernod Ricard
EU
ML
Michelin
NYSE
JPM
JP Morgan Chase
EU
GLE
Societe Generale
EU
PX1
CAC 40
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés